XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statement of Stockholders' Equity - USD ($)
Common Stock [Member]
Class A Common Stock [Member]
Common Stock [Member]
Class A Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Class B Common Stock [Member]
Common Stock [Member]
Class B Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Loss [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock [Member]
Treasury Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Beginning balance at Dec. 31, 2022 $ 301,203   $ 56,492   $ 325,601,647   $ (41,703,747)   $ 240,563,774   $ (41,226,357)   $ 483,593,012  
Beginning balance (ASU 2016-13 [Member]) at Dec. 31, 2022   $ 0   $ 0   $ 0   $ 0   $ (1,895,902)   $ 0   $ (1,895,902)
Beginning balance (in shares) at Dec. 31, 2022 30,120,263   5,649,240                      
Beginning balance (in shares) (ASU 2016-13 [Member]) at Dec. 31, 2022   0   0                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock (stock compensation plans) $ 350   $ 0   440,746   0   0   0   441,096  
Issuance of common stock (stock compensation plans) (in shares) 35,045   0                      
Share-based compensation $ 1,431   $ 0   2,218,355   0   0   0   2,219,786  
Share-based compensation (in shares) 143,004   0                      
Net income $ 0   $ 0   0   0   5,203,596   0   5,203,596  
Cash dividends declared 0   0   0   0   (7,057)   0   (7,057)  
Grant of stock options 0   0   114,724   0   (114,724)   0   0  
Other comprehensive income (loss) 0   0   0   4,007,638   0   0   4,007,638  
Ending balance at Mar. 31, 2023 $ 302,984   $ 56,492   328,375,472   (37,696,109)   243,749,687   (41,226,357)   493,562,169  
Ending balance (in shares) at Mar. 31, 2023 30,298,312   5,649,240                      
Beginning balance at Dec. 31, 2023 $ 307,646   $ 56,492   335,694,478   (32,881,822)   217,794,917   (41,226,357)   479,745,354  
Beginning balance (in shares) at Dec. 31, 2023 30,764,555   5,649,240                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock (stock compensation plans) $ 383   $ 0   472,740   0   0   0   473,123  
Issuance of common stock (stock compensation plans) (in shares) 38,287   0                      
Share-based compensation $ 164   $ 0   522,460   0   0   0   522,624  
Share-based compensation (in shares) 16,400   0                      
Net income $ 0   $ 0   0   0   5,955,551   0   5,955,551  
Cash dividends declared 0   0   0   0   (8,888)   0   (8,888)  
Grant of stock options 0   0   128,267   0   (128,267)   0   0  
Other comprehensive income (loss) 0   0   0   (1,601,290)   0   0   (1,601,290)  
Ending balance at Mar. 31, 2024 $ 308,193   $ 56,492   $ 336,817,945   $ (34,483,112)   $ 223,613,313   $ (41,226,357)   $ 485,086,474  
Ending balance (in shares) at Mar. 31, 2024 30,819,242   5,649,240